Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors

Autor: Massimo Cugno, Dario Consonni, Andrea Lombardi, Patrizia Bono, Massimo Oggioni, Sara Uceda Renteria, Angela Cecilia Pesatori, Silvana Castaldi, Luciano Riboldi, Lorenzo Bordini, Carlo Domenico Nava, Ferruccio Ceriotti, Adriana Torri, Francesco Tafuri, Gabriele Ghigliazza, Flora Peyvandi, Alessandra Bandera, Andrea Gori
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Vaccines, Vol 9, Iss 9, p 1011 (2021)
Druh dokumentu: article
ISSN: 2076-393X
DOI: 10.3390/vaccines9091011
Popis: Urticarial eruptions and angioedema are the most common cutaneous reactions in patients undergoing mRNA COVID-19 vaccinations. The vasoactive peptide bradykinin has long been known to be involved in angioedema and recently also in urticaria. Bradykinin is mainly catabolized by angiotensin-converting enzyme (ACE), which is inhibited by ACE inhibitors, a commonly employed class of antihypertensive drugs. We evaluated the risk of developing urticaria/angioedema after inoculation with the BNT162b2 mRNA COVID-19 vaccine in a population of 3586 health care workers. The influences of ACE inhibitors and selected potential confounding variables (sex, age, previous SARS-CoV-2 infection, and allergy history) were evaluated by fitting univariate and multivariable Poisson regression models. The overall cumulative incidence of urticaria/angioedema was 1.8% (65 out of 3586; 95% CI: 1.4–2.3%). Symptoms were mild, and no subject consulted a physician. Subjects taking ACE inhibitors had an adjusted three-fold increased risk of urticaria/angioedema (RR 2.98, 95% CI: 1.12–7.96). When we restricted the analysis to those aged 50 years or more, the adjusted RR was 3.98 (95% CI: 1.44–11.0). In conclusion, our data indicate that subjects taking ACE inhibitors have an increased risk of urticaria/angioedema after vaccination with the BNT162b2 mRNA COVID-19 vaccine. Symptoms are mild and self-limited; however, they should be considered to adequately advise subjects undergoing vaccination.
Databáze: Directory of Open Access Journals